<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The research of biological activity of <z:chebi fb="7" ids="16670">peptide</z:chebi> geroprotector Slavinorm on the basis of calf aorta extract was conducted in experimental models of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:chebi fb="76" ids="17996">chloride</z:chebi>-calcium <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The research results showed that in experimental model of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in rats induced by pituitrin administration, intraventricular and intramuscular introduction of Slavinorm in therapeutical dose had caused to leveling of <z:hpo ids='HP_0000822'>hypertension</z:hpo> symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>That was expressed in normalization of blood pressure characteristics, body weight, heart and kidney weight </plain></SENT>
<SENT sid="3" pm="."><plain>In the experimental model of <z:chebi fb="76" ids="17996">chloride</z:chebi>-calcium <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in rats inrtaventricular and intramuscular introduction of Slavinorm showed the ability to predict the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> development caused by the <z:chebi fb="26" ids="3312">Calcium Chloride</z:chebi> administration </plain></SENT>
<SENT sid="4" pm="."><plain>The research results testify to availability of the medication research in the capacity of the medication for treatment of age related pathology conditioned by vessels impaired function </plain></SENT>
</text></document>